Current and future developments of immunotherapy in lung cancer

This article summarizes the current evidence for ICIs in early and advanced NSCLC as well as in SCLC. Furthermore, current data and ongoing clinical trials on combination therapies are discussed as well as challenges of immunotherapy in lung cancer patients.
Source: Memo - Magazine of European Medical Oncology - Category: Cancer & Oncology Source Type: research